Prognostic value of impaired myocardial fatty acid uptake in patients with acute myocardial infarction

Nuclear Medicine Communications

Volumn 21, Issue 10, 2000, Pages 897-906

  Nakata, T ^a   Kobayashi, T ^b   Tamaki, N ^b   Kobayashi, H ^b   Wakabayashi, T ^b   Shimoshige, S ^b   Oh Hori, K ^b   Hamabe, K ^b   Hirasawa, K ^b   Matsuki, T ^b   Shogase, T ^b   Furudate, M ^b   Shimamoto, K ^b  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; FATTY ACID; IODOBENZENE; IODOFILTIC ACID; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; THALLIUM;

ACTIVE TRANSPORT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; FOLLOW UP; HEART; HEART INFARCTION; HEART MUSCLE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PROGNOSIS; RECURRENT DISEASE; SCINTISCANNING; SUDDEN DEATH;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT, ACTIVE; DEATH, SUDDEN, CARDIAC; FATTY ACIDS; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PROGNOSIS; RADIOPHARMACEUTICALS; RECURRENCE; THALLIUM RADIOISOTOPES;

EID: 0034297033     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200010000-00003     Document Type: Article

References (28)

1. Eitzman D, al Aouar Z, Kanter HL et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992; 20: 559-565.
2. Di Carli MF, Davidson M, Little R et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73: 527-533.
3. Tamaki N, Kawamoto M, Takahashi N et al. Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging. J Am Coll Cardiol 1993; 22: 1621-1627.
4. 99mTc-sestamibi. Ann Nucl Med 1995; 9: 125-130.
5. Matsunari I, Saga T, Taki J et al. Improved myocardial fatty acid utilization after percutaneous transmural coronary angioplasty. J Nucl Med 1995; 36: 1605-1607.
6. Taki J, Nakajima K, Matsunari I et al. Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP. J Nucl Med 1997; 38: 1503-1510.
7. Tamaki N, Kawamoto M, Yonekura Y et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992; 33: 659-667.
8. Kawamoto M, Tamaki N, Yonekura Y et al. Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism. Ann Nucl Med 1994; 8: 47-54.
9. Hashimoto A, Nakata T, Nagao K et al. Prediction of left ventricular functional recovery in patients with acute myocardial infarction using SPECT with thallium and beta-methyl iodophenyl pentadecanoic acid. J Cardiol 1995; 26: 35-44.
10. Franken PR, Dendale P, De Geeter F et al. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med 1996; 37: 718-722.
11. Hashimoto A, Nakata T, Tsuchihashi K et al. Postischemic functional recovery and BMIPP uptake after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. Am J Cardiol 1996; 77: 25-30.
12. Hashimoto A, Nakata T, Kobayashi H, Tsuchihashi K, Shimamoto K. Correlation of fatty acid metabolism and contractile reserve assessed by BMIPP SPECT and postextrasystolic potentiation in acute myocardial infarction. J Nucl Cardiol 1997; 4(Suppl): S44
13. Nakata T, Hashimoto A, Kobayashi H et al. Outcome significance of Tl-201 and I-123 BMIPP perfusion-metabolism mismatch in pre-infarction angina. J Nucl Med 1998; 39: 1492-1499.
14. Tamaki N, Tadamura E, Kudoh et al. Prognostic value of iodine-123 labeled BMIPP fatty acid analogue imaging in patients with myocardial infarction. Eur J Nucl Med 1996; 23: 272-279.
15. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for the ‘hibernation myocardium’. J Am Coll Cardiol 1986; 8: 1467-1470.
16. Bolli R. Myocardial ‘stunning’ in man. Circulation 1992; 25: 1671-1691.
17. Nakata T, Tamaki N, Kobayashi T et al. Prognostic implications of impaired myocardial fatty acid uptake in acute myocardial infarction: a multicenter study. J Nucl Med 1998; 39: 127P
18. Shaw LJ, Peterson ED, Kesler K et al. A metanalysis of predischarge risk stratification after myocardial infarction with stress electrocardiographic myocardial perfusion, and ventricular function imaging. Am J Cardiol 1996; 78: 1327-1337.
19. Ritchie JL, Bateman TM, Bonow RO et al. Guidelines for clinical use of cardiac radionuclide imaging. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures, Committee on Radionuclide Imaging, developed in collaboration with the American Society of Nuclear Cardiology. Circulation 1995; 91: 1278-1303.
20. O'Rourke RA. Risk stratification after myocardial infarction. Clinical overview. Circulation 1991; 84(Suppl I): I-177-I-181.
21. Stevenson R, Umachandran V, Ranjadayalan K et al. Reassessment of treadmill stress testing for risk stratification in patients with acute myocardial infarction treated by thrombolysis. Br Heart J 1993; 70: 415-420.
22. Basu S, Senior R, Dore C et al. Value of thallium-201 imaging in detecting adverse cardiac events after myocardial infarction and thrombolysis: a follow up of 100 consecutive patients. Br Med J 1996; 313: 844-848.
23. Boden WE, O'Rourke RA, Crawford MH et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. New Engl J Med 1998; 338: 1785-1792.
24. Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 1990; 66: 913-931.
25. Fujibayashi Y, Yonekura Y, Takemura Y et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3(R, S) methyl pentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990; 31: 1818-1822.
26. Schwaiger M, Schelbert H, Ellison D et al. Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol 1985; 6: 336-346.
27. Nienaber CA, Brunken RC, Sherman CT et al. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol 1991; 18: 966-978.
28. Petretta M, Cuocolo A, Nicolai E et al. Combined assessment of left ventricular function and rest-redistribution regional myocardial thallium-201 activity for prognostic evaluation of patients with chronic coronary artery disease and left ventricular dysfunction. J Nucl Cardiol 1998; 5: 378-386.